flucytosine has been researched along with ketoconazole in 209 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 93 (44.50) | 18.7374 |
1990's | 73 (34.93) | 18.2507 |
2000's | 30 (14.35) | 29.6817 |
2010's | 13 (6.22) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gunawardana, GP; Kelly-Borges, M; McCarthy, PJ; Pitts, TP; Pomponi, SA | 1 |
Alvarez-Pedraglio, A; Colmenarejo, G; Lavandera, JL | 1 |
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Abonía, R; Delgado, P; Enriz, RD; Garibotto, FM; Insuasty, B; Juárez, S; Nogueras, M; Quiroga, J; Rodero, L; Sortino, M; Zacchino, SA | 1 |
Alvarado-Ramírez, E; Torres-Rodríguez, JM | 1 |
Almyroudis, NG; Fothergill, AW; Kusne, S; Rinaldi, MG; Sutton, DA | 1 |
Khan, NA; Matin, A; Siddiqui, R; Stins, M; Warhurst, D | 1 |
Enriz, RD; Freile, M; Gupta, MP; Kouznetsov, VV; Sortino, M; Vargas Méndez, LY; Vásquez, Y; Zacchino, SA | 1 |
Cano, J; Gené, J; Guarro, J; Marimon, R; Serena, C | 1 |
Buitrago, MJ; Cuenca-Estrella, M; Gomez-Lopez, A; Gutierrez, MO; Rodriguez-Tudela, JL | 1 |
Jin, LJ; Samaranayake, LP; Samaranayake, YH; Seneviratne, CJ | 1 |
Cannon, RD; Holmes, AR; Lamping, E; Nakamura, K; Niimi, K; Niimi, M; Ranchod, A; Tyndall, JD | 1 |
Gao, C; Pang, G; Sun, S; Wang, B; Xu, Y; Zhao, D; Zhou, L | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Ghosh, I; Manoharlal, R; Prakash, O; Prasad, R; Puri, N; Sharma, M | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Bowlin, TL; Ding, X; Kwasny, SM; Nguyen, ST; Opperman, TJ; Peet, NP; Williams, JD | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Denning, DW; Hanson, LH; Perlman, AM; Stevens, DA | 1 |
de Gans, J; Eeftinck Schattenkerk, JK; Portegies, P; Stam, J; Tiessens, G; van Boxtel, CJ; van Ketel, RJ | 1 |
Cajot, MA; Gosselin, B; Goullard, L; Koussa, A; Marquette, F; Pol, A; Roux, JP; Soots, G; Warembourg, H | 1 |
Bayles, MA | 1 |
Van Cutsem, J | 1 |
Carbon, C; Eloy, O; Ghnassia, JC; Joly, V; Yeni, P | 1 |
Bava, AJ; Negroni, R | 1 |
Büchner, T; Roos, N | 1 |
Lode, H; Schaberg, T | 1 |
al-Abedeen Jamjoom, Z; al-Hedaithy, S; Jamali, A; Jamjoom, A; Malabarey, T | 1 |
Lozano, MC; Martín, E; Parras, P | 1 |
Chotmongkol, V; Sookprasert, A | 1 |
Kujala, P; Ruutu, P | 1 |
Hernández Molina, JM; Llosá, J; Martinez Brocal, A; Ventosa, A | 1 |
Kurata, H; Matsuoka, H; Oh, K; Sumita, O; Takatori, K | 1 |
Lelarge, P; Mariot, J | 1 |
de Montclos, H; de Montclos, M; Flandrois, JP | 1 |
Cobbs, CG; Dismukes, WE; Lank, KM; Smith, KR | 1 |
Bolzinger, T; Pradinaud, R | 1 |
Gerarden, T; Hollis, R; Isenberg, HD; Levenson, D; Pfaller, MA; Smith, MA; Tucci, CB | 1 |
Carrasco, R; Cervelló, A; Navarro, V; Nieto, A; Roig, P; Salavert, M | 1 |
de Pauw, BE; Fibbe, WE; Novakova, I; van der Meer, JW; van't Wout, JW; Verhagen, CA | 1 |
Shindo, K | 1 |
Dettori, G; Manzara, S; Morace, G | 1 |
Barriere, SL | 1 |
Chatterjee, PK; Sharma, S; Singh, SM | 1 |
Arning, M; Scharf, RE; Schneider, W; Wolf, HH | 1 |
Andreassian, B; Bouttier, S; Branger, C; Elzaabi, M; Icard, P; Nussaume, O | 1 |
Brod, RD; Clarkson, JG; Culbertson, WW; Flynn, HW; Miller, D; Pflugfelder, SC | 1 |
Cook, RA; Galgiani, JN; McIntyre, KA | 1 |
Bartlett, MS; Body, BA; Espinel-Ingroff, A; Fromtling, RA; Galgiani, JN; Hall, GS; Hughes, CE; Odds, FC; Pfaller, MA; Rinaldi, MG | 1 |
Herrod, HG | 1 |
Burke, J; Johnson, EM; Pracharktam, R; Warnock, DW | 1 |
Dupont, B | 1 |
Blancard, A; Goudard, M; Mary, C; Quilici, M; Regli, P | 1 |
Handrick, W; Hückel, D; Schönborn, C; Spencker, FB | 1 |
Herz, F; McKitrick, JC; Roth, EF | 1 |
Radentz, WH | 1 |
Dwernicka, B; Macura, AB | 1 |
Ray, TL | 1 |
Chuck, SL; Sande, MA | 1 |
Cotton, MF; Ransome, OJ | 1 |
Polak, A | 2 |
Longman, LP; Martin, MV | 1 |
Walsh, TJ | 1 |
Pizzo, A; Walsh, TJ | 1 |
Ackerbauer, H; Meingassner, JG; Mieth, H | 1 |
Abbott, AB; Cockayne, A; Hayward, J; Odds, FC | 1 |
Abruzzo, GK; Bulmer, GS; Fromtling, RA | 1 |
Borgers, M; Cauwenbergh, G; Vanden Bossche, H | 1 |
Davies, SP; Denning, DW; Murray, WK; Patou, G; Webb, WJ | 1 |
Cavanna, C; Garavelli, PL; Maccabruni, A; Michelone, G | 1 |
Gerarden, T; Pfaller, MA; Wenzel, RP; Yu, M | 1 |
Bottone, EJ; Cronin, DC; Poon, M; Wormser, GP | 1 |
Buffard, Y; Gabriel, B; Goudard, M; Regli, P | 1 |
Bodey, GP | 1 |
Davis, CP; Gudewicz, TM; Mader, JT | 1 |
Cabrita, J; Cachão, P; Rocha, MM; Rodrigo, JG | 1 |
Dorsch, R; Korting, HC | 1 |
Bacher, J; O'Leary, T; Pizzo, PA; Thaler, M | 1 |
Feld, R; Haron, E; Hasselback, R; Matlow, A; Patterson, B; Tuffnell, P | 1 |
Head, WS; O'Day, DM; Robinson, RD | 1 |
Barrie, T | 1 |
Meyer, RD | 1 |
Brenciaglia, MI; Cipriani, P; Ghezzi, MC; Mancini, C; Trancassini, M | 1 |
Beggs, WH; Gerding, DN; Hughes, CE; Peterson, LR | 1 |
Chapin, K; Doern, GV; Rinaldi, MG; Tubert, TA | 1 |
Abu Aisha, H; Chagla, AH; Laajam, M; Yaqoub, B | 1 |
Chan, FL; Huang, CY; Kwong, YL; Lam, KS; Woo, E; Yu, YL | 1 |
Brass, C; Espinel-Ingroff, A; Galgiani, JN; Gordon, MA; Kerkering, TM; Reiser, J | 1 |
Bevier, D; Panciera, DL | 1 |
Anandakrishnan, C; Attapattu, MC | 1 |
Ceuppens, AM; Heymans, C; Meunier, F; Van der Auwera, P | 1 |
Ito, A | 1 |
Radetsky, M; Roe, MH; Todd, JK; Wheeler, RC | 1 |
Atukorala, DN; Pothupitiya, GM | 1 |
Drouhet, E; Dupont, B | 1 |
Arosio, E; Dean, P; Lechi, A; Montesi, G; Pancera, P | 1 |
Freeman, JM; Head, WS; O'Day, DM; Robinson, RD; Stern, WH | 1 |
Ahmad, S; Gallagher, N; Johnson, RJ; Ramsey, PG | 1 |
Baudraz-Rosselet, F; Calandra, T; Francioli, P; Glauser, MP; Grigoriu, D; Ruffieux, C | 1 |
Bodet, CA; Drutz, DJ; Jorgensen, JH | 1 |
Tan, CB; Tjia, TL; Yeow, YK | 1 |
Ho, NK | 1 |
Katzenstein, D | 1 |
Irvine, AR; Jacobs, RA; O'Day, DM; Pons, VG; Stern, WH; Stone, RD; Tamura, E | 1 |
Barkve, H; Langberg, CW; Tjørstad, K | 1 |
Kostiala, AA; Kostiala, I | 1 |
Lefrock, JL; Smith, BR | 1 |
Case, P; Kaplan, W; Neuman, MA; Padhye, AA; Radcliffe, GN | 1 |
Anagnostopoulos, C; Lerner, SA; Resnekov, L; Samelson, LE | 1 |
Foster, CS; Giovanoni, R; Lass, JH; Moran-Wallace, K | 1 |
Arai, T | 1 |
Högl, F; Raab, W | 1 |
Beggs, WH; Sarosi, GA | 1 |
Roberts, DT | 1 |
Jones, HE | 1 |
Durack, DT; Perfect, JR | 1 |
Corrado, ML; Cummings, M; Eng, RH; Kramer, M | 1 |
Höffken, G; Lode, H | 1 |
Hironaga, M; Mochizuki, T; Watanabe, S | 1 |
Odds, FC | 1 |
Polak, A; Scholer, HJ; Wall, M | 1 |
Craven, PC; Graybill, JR | 2 |
Brabender, W; Hodges, GR | 1 |
Dismukes, WE; Stamm, AM | 1 |
Scholer, HJ | 1 |
Bolard, J; Brajtburg, J; Kobayashi, GS; Medoff, G | 1 |
Roselle, GA; Warth, P | 1 |
Pohjola-Sintonen, S; Ruutu, P; Tallroth, K | 1 |
Head, WS; O'Day, DM; Ray, WA; Robinson, R | 1 |
Plempel, M | 2 |
Ahearn, DG; McGlohn, MS | 1 |
Okafor, JI; TeStrake, D; Yangco, BG | 1 |
Gerding, DN; Harris, C; Hughes, CE; Moody, JA; Peterson, LR | 1 |
Head, WS; O'Day, DM; Ray, WA; Robinson, RD | 1 |
Feld, R; Rusthoven, JJ; Tuffnell, PG | 1 |
Martinez-Suárez, JV; Rodriguez-Tudela, JL | 1 |
Hoeprich, PD | 1 |
Belcher, KE; Law, EJ; Spencer, SA; Still, JM | 1 |
Craig, WA; Gudmundsson, S; Turnidge, JD; Vogelman, B | 1 |
Ancarani, F; Arzeni, D; Barchiesi, F; Del Poeta, M; Marinucci, G; Morbiducci, V; Scalise, G | 1 |
Dubé, MP; Evans, S; Heseltine, PN; Rinaldi, MG; Zawacki, B | 1 |
Bickers, DR | 1 |
al Khayat, R; Courdavault, L; Michel, C; Mignon, F; Roux, P; Viron, B | 1 |
Chotmongkol, V; Jitpimolmard, S | 1 |
Bolzonella, R; Contestabile, A; Fabris, A; Gardin, C; Pellanda, MV | 1 |
Catalin, J; Durand, A; Lacarelle, B; Rajaonarison, JF; Sampol, E | 1 |
Bolmström, A; Messer, SA; Odds, FC; Pfaller, MA; Rex, JH | 1 |
Boyvat, A; Geilen, CC; Orfanos, CE; Seibold, M; Tebbe, B; Wölfer, LU | 1 |
Finielz, P; Guiserix, J; Michault, A; Rajaonarivelo, P; Ramdane, M | 1 |
Chiu, ML; Garcia, MT; Lima, JF; Minguez, F; Prieto, J; Salazar, EF | 1 |
Chiu, ML; Garcia, MT; Guardiola, L; Lima, JE; Minguez, F; Prieto, J | 1 |
Cuenca, M; Gadea, I; Gegúndez, MI; Soriano, F; Valero, ML; Zapardiel, J | 1 |
Adeyemi-Doro, FA; Chan, RC; Cheng, AF; Cheung, SW; Ng, TK | 1 |
Batura-Gabryel, H; Mlynarczyk, W; Wieczorek, U | 1 |
Berenguer Berenguer, J | 1 |
Ghannoum, MA; Hawser, SP; Jessup, CJ; Norris, H | 1 |
Ellepola, AN; Samaranayake, LP | 5 |
Casal, M; Linares, MJ; Muñoz, JF; Rodríguez, FC; Solís, F; Valero, A | 1 |
Daza, RM; Martín, JE; Martín, P; Martínez, MM; Mendaza, P; Portero, F; Sánchez, G | 1 |
Araj, GF; Daher, NK; Tabbarah, ZA | 1 |
Espinel-Ingroff, A; Ghannoum, MA; Killian, S; Knapp, CC; Messer, SA; Norris, HA; Pfaller, M | 1 |
Desmet, P; Raes-Wuytack, C; Swinne, D; Van Looveren, K | 1 |
Chang, HC; Chang, JJ; Chang, TC; Huang, AH | 1 |
Govender, S; Mutasa, E; Parbhoo, AH | 1 |
Apfalter, P; Hirschl, AM; Makristathis, A; Rotter, M; Seibold, M; Willinger, B | 1 |
Guarro, J; Llop, C; Riba, MD; Sala, J | 1 |
García, MT; Llorente, MT; Mínguez, F; Prieto, J | 1 |
Barchiesi, F; Cogliati, M; Di Francesco, LF; Scalise, G; Tortorano, AM; Viviani, MA | 1 |
Anil, S; Ellepola, AN; Samaranayake, LP | 1 |
Torres-Rodríguez, JM; Vivas, JR | 1 |
Engelen, M; Rochette, F; Vanden Bossche, H | 1 |
del Palacio, A; Garau, M; Pereiro, M | 1 |
Fehér, J; Lengyel, G | 1 |
Bliss, JM; Gigliotti, F; Wellington, M | 1 |
Gangneux, JP; Guiguen, C; Preney, L; Théraud, M | 1 |
Al Hedaithy, SS; Fotedar, R | 1 |
Abbasoğlu, U; Cesur, S; Citak, S; Içli, F; Ozçelik, B | 1 |
Barker, KS; Homayouni, R; Lee, RE; Liu, TT; Rogers, PD; Wei, L | 1 |
Braun, JJ; de Blay, F; Pauli, G | 1 |
Hamimah, H; Ng, KP; Rohani, MY; Tanty Haryanty, T; Tay, ST | 1 |
Cano, J; Gené, J; Gilgado, F; Guarro, J; Serena, C | 1 |
Avolio, M; Bruschetta, G; Camporese, A; De Rosa, R; Grosso, S | 1 |
Jayatilake, JA; Samaranayake, LP; Samaranayake, YH; Thein, ZM; Yau, JY; Yeung, KW | 1 |
Meurman, JH; Pärnänen, P; Samaranayake, LP; Seneviratne, CJ; Vaara, M; Wong, SS; Yuen, KY | 1 |
Braga, JA; Brighenti, FL; Figueiredo, MS; Koga-Ito, CY; Pereira, DF; Salvia, AC | 1 |
Bulanda, M; Jagielski, T; Skóra, M | 1 |
Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
31 review(s) available for flucytosine and ketoconazole
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Primary Aspergillus endocarditis. Apropos of a case and review of the international literature].
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Combined Modality Therapy; Drug Therapy, Combination; Endocarditis; Flucytosine; Humans; Itraconazole; Ketoconazole; Male; Middle Aged; Recurrence; Reoperation | 1992 |
[Choice and monitoring of the treatment of systemic mycoses. Value and limitations of in vitro tests].
Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Antifungal Agents; Candida; Candidiasis; Drug Therapy, Combination; Fluconazole; Flucytosine; Humans; In Vitro Techniques; Itraconazole; Ketoconazole; Opportunistic Infections | 1992 |
Antifungal treatment strategy in leukemia patients.
Topics: Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Leukemia; Mycoses; Tomography, X-Ray Computed | 1992 |
[Therapy of pulmonary mycoses].
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillosis, Allergic Bronchopulmonary; Blastomycosis; Coccidioidomycosis; Cryptococcosis; Fluconazole; Flucytosine; Histoplasmosis; Humans; Itraconazole; Ketoconazole; Lung Diseases, Fungal | 1992 |
[Systemic antifungal drugs].
Topics: Amphotericin B; Animals; Antifungal Agents; Flucytosine; Humans; In Vitro Techniques; Itraconazole; Ketoconazole; Miconazole; Mycoses; Rabbits | 1991 |
[Systemic candidiasis].
Topics: Amphotericin B; Candida; Candidiasis; Decontamination; Drug Therapy, Combination; Female; Flucytosine; Humans; Ketoconazole; Male; Miconazole | 1992 |
Laboratory monitoring of antifungal chemotherapy. British Society for Antimicrobial Chemotherapy Working Party.
Topics: Adult; Amphotericin B; Antifungal Agents; Chromatography, High Pressure Liquid; Drug Resistance; Drug Therapy, Combination; Fluconazole; Flucytosine; Humans; Immunodiffusion; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Mycoses | 1991 |
Pharmacology and pharmacokinetics of traditional systemic antifungal agents.
Topics: Amphotericin B; Flucytosine; Humans; Ketoconazole; Miconazole | 1990 |
Opportunistic fungal infections in immunocompromised hosts.
Topics: Amphotericin B; Dermatomycoses; Flucytosine; Humans; Immunosuppression Therapy; Ketoconazole; Opportunistic Infections | 1989 |
Systemic candidiasis.
Topics: Amphotericin B; Candidiasis; Flucytosine; Humans; Immune Tolerance; Ketoconazole; Neoplasms; Opportunistic Infections; Risk Factors | 1989 |
Recent advances in the treatment of systemic fungal infections.
Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Antifungal Agents; Drug Resistance, Microbial; Drug Therapy, Combination; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Miconazole; Mycoses; Triazoles | 1987 |
Treatment of systemic fungal infections: recent progress and current problems.
Topics: Amphotericin B; Antifungal Agents; Chemical Phenomena; Chemistry; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Miconazole; Mycoses; Triazoles | 1988 |
The pharmacology of agents used in the treatment of pulmonary mycoses.
Topics: Amphotericin B; Antifungal Agents; Drug Interactions; Flucytosine; Humans; Itraconazole; Ketoconazole; Lung Diseases, Fungal; Miconazole | 1986 |
Topical and systemic antifungal agents.
Topics: Administration, Topical; Amphotericin B; Antifungal Agents; Dermatomycoses; Flucytosine; Humans; Ketoconazole; Miconazole; Mycoses | 1988 |
Cutaneous and mucosal manifestations of the deep mycotic infections.
Topics: Amphotericin B; Aspergillosis; Blastomycosis; Candidiasis; Candidiasis, Cutaneous; Coccidioidomycosis; Cryptococcosis; Dermatomycoses; Flucytosine; Histoplasmosis; Humans; Immunosuppression Therapy; Ketoconazole; Miconazole; Mouth Diseases; Mouth Mucosa; Mucormycosis; Mycoses; Paracoccidioidomycosis; Sporotrichosis; Travel | 1986 |
[Action mechanism and resistance of drugs used in visceral mycoses].
Topics: Animals; Antifungal Agents; Candida albicans; Chemical Phenomena; Chemistry; Clotrimazole; Drug Resistance, Microbial; Flucytosine; Humans; Imidazoles; Ketoconazole; Mice; Mycoses; Piperazines | 1980 |
The current status of systemic antifungal agents.
Topics: Amphotericin B; Antifungal Agents; Flucytosine; Griseofulvin; Humans; Imidazoles; Ketoconazole; Miconazole; Mycoses; Piperazines | 1982 |
[Systemic antimycotic treatment].
Topics: Amphotericin B; Drug Therapy, Combination; Flucytosine; Griseofulvin; Humans; Imidazoles; Iodides; Ketoconazole; Miconazole; Mycoses; Piperazines; Transfer Factor | 1982 |
Antifungal agents used in systemic mycoses. Activity and therapeutic use.
Topics: Amphotericin B; Antifungal Agents; Central Nervous System; Flucytosine; Humans; Imidazoles; Ketoconazole; Kidney; Kidney Diseases; Kinetics; Miconazole; Mycoses; Piperazines | 1983 |
Current therapy of pulmonary and disseminated fungal diseases.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Blastomycosis; Candidiasis; Chromoblastomycosis; Coccidioidomycosis; Cryptococcosis; Flucytosine; Histoplasmosis; Humans; Imidazoles; Ketoconazole; Lung Diseases, Fungal; Miconazole; Mycoses; Nausea; Piperazines; Vomiting | 1983 |
[Chemotherapy of aspergillus lung disease].
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Drug Therapy, Combination; Flucytosine; Humans; Imidazoles; Ketoconazole; Lung Diseases, Fungal; Miconazole; Piperazines | 1983 |
Antifungal agents useful in therapy of systemic fungal infections.
Topics: Amphotericin B; Animals; Antifungal Agents; Binding, Competitive; Cholesterol; Ergosterol; Flucytosine; Fungi; Humans; Imidazoles; Ketoconazole; Membranes, Artificial; Miconazole; Mycoses; Phospholipids; Piperazines; Sterols | 1983 |
Antifungal chemotherapy.
Topics: Amphotericin B; Antifungal Agents; Fluconazole; Flucytosine; Itraconazole; Ketoconazole; Morpholines; Naphthalenes; Terbinafine | 1995 |
Antifungal therapy: potential interactions with other classes of drugs.
Topics: Amphotericin B; Antifungal Agents; Drug Interactions; Drug Synergism; Drug Therapy, Combination; Fluconazole; Flucytosine; Griseofulvin; Humans; Itraconazole; Ketoconazole; Mycoses | 1994 |
Fungal peritonitis in patients on peritoneal dialysis.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antifungal Agents; Candidiasis; Drug Administration Routes; Drug Therapy, Combination; Female; Fluconazole; Flucytosine; Humans; Ketoconazole; Kidney Failure, Chronic; Length of Stay; Male; Middle Aged; Mycoses; Peritoneal Dialysis; Peritonitis; Risk Factors; Treatment Outcome | 1994 |
[Commonly used antifungal agents in the treatment of systemic mycoses].
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Blastomycosis; Candidiasis; Clinical Trials as Topic; Coccidioidomycosis; Cryptococcosis; Fluconazole; Flucytosine; Hematologic Diseases; Histoplasmosis; Humans; Itraconazole; Ketoconazole; Kidney; Mycoses; Thrombophlebitis | 1995 |
Oral candidal infections and antimycotics.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Anti-Infective Agents, Local; Antifungal Agents; Candida; Candidiasis, Oral; Chlorhexidine; Clotrimazole; Drug Resistance, Fungal; Fluconazole; Flucytosine; Humans; Immunocompromised Host; Itraconazole; Ketoconazole; Miconazole; Mouth; Nystatin; Opportunistic Infections; Saliva; Treatment Failure; Triazoles | 2000 |
Antifungal agents of use in animal health--chemical, biochemical and pharmacological aspects.
Topics: Animals; Antifungal Agents; Clotrimazole; Drug Resistance, Fungal; Econazole; Fluconazole; Flucytosine; Griseofulvin; Imidazoles; Itraconazole; Ketoconazole; Miconazole; Naphthalenes; Natamycin; Nystatin; Terbinafine; Thiabendazole; Tolnaftate; Veterinary Drugs | 2003 |
[Therapeutic safety of antimycotics in the treatment of systemic fungal infections].
Topics: Amphotericin B; Antifungal Agents; Drug Interactions; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Liver; Mycoses | 2003 |
Antifungal pharmacotherapy for neonatal candidiasis.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Caspofungin; Cross Infection; Echinocandins; Fluconazole; Flucytosine; Fungal Proteins; Fungemia; Humans; Infant, Newborn; Infant, Premature; Intensive Care Units, Neonatal; Ketoconazole; Lipopeptides; Peptides; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2003 |
3 trial(s) available for flucytosine and ketoconazole
Article | Year |
---|---|
Itraconazole compared with amphotericin B plus flucytosine in AIDS patients with cryptococcal meningitis.
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Flucytosine; Humans; Itraconazole; Ketoconazole; Male; Meningitis, Cryptococcal; Middle Aged; Opportunistic Infections; Prospective Studies; Survival Analysis | 1992 |
The efficacy of itraconazole against systemic fungal infections in neutropenic patients: a randomised comparative study with amphotericin B.
Topics: Amphotericin B; Aspergillosis; Aspergillus fumigatus; Candidiasis; Drug Therapy, Combination; Female; Flucytosine; Humans; Itraconazole; Ketoconazole; Male; Middle Aged; Neutropenia; Prospective Studies | 1991 |
Collaborative investigation of variables in susceptibility testing of yeasts.
Topics: Amphotericin B; Candida; Cell Division; Culture Media; Evaluation Studies as Topic; Flucytosine; Ketoconazole; Microbial Sensitivity Tests; Microbiological Techniques; Temperature; Time Factors | 1990 |
175 other study(ies) available for flucytosine and ketoconazole
Article | Year |
---|---|
Antifungal activity of meridine, a natural product from the marine sponge Corticium sp.
Topics: Alkaloids; Animals; Antifungal Agents; DNA, Fungal; Fungi; Microbial Sensitivity Tests; Porifera | 1992 |
Cheminformatic models to predict binding affinities to human serum albumin.
Topics: Adrenergic beta-Antagonists; Antidepressive Agents, Tricyclic; Chromatography, Affinity; Cyclooxygenase Inhibitors; Databases, Factual; Humans; Hydrophobic and Hydrophilic Interactions; Penicillins; Pharmaceutical Preparations; Protein Binding; Quantitative Structure-Activity Relationship; Reproducibility of Results; Serum Albumin; Steroids | 2001 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Synthesis and antifungal activity of (Z)-5-arylidenerhodanines.
Topics: Antifungal Agents; Computer Simulation; Drug Design; Microbial Sensitivity Tests; Microwaves; Mitosporic Fungi; Molecular Structure; Rhodanine; Sensitivity and Specificity; Stereoisomerism; Structure-Activity Relationship; Yeasts | 2007 |
In vitro susceptibility of Sporothrix schenckii to six antifungal agents determined using three different methods.
Topics: Amphotericin B; Antifungal Agents; Fluconazole; Flucytosine; Humans; In Vitro Techniques; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Pyrimidines; Quality Control; Sporothrix; Sporotrichosis; Triazoles; Voriconazole | 2007 |
In vitro susceptibilities of 217 clinical isolates of zygomycetes to conventional and new antifungal agents.
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Fluconazole; Flucytosine; Humans; In Vitro Techniques; Itraconazole; Ketoconazole; Lipopeptides; Microbial Sensitivity Tests; Mucormycosis; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2007 |
Effect of antimicrobial compounds on Balamuthia mandrillaris encystment and human brain microvascular endothelial cell cytopathogenicity.
Topics: Actins; Amebicides; Amoeba; Animals; Cell Line; Cell Survival; Cycloheximide; Cytochalasin D; Cytoskeleton; Dose-Response Relationship, Drug; Endothelial Cells; Ergosterol; Humans; Ketoconazole | 2007 |
Antifungal and cytotoxic activities of some N-substituted aniline derivatives bearing a hetaryl fragment.
Topics: Aniline Compounds; Antifungal Agents; Antineoplastic Agents; Drug Screening Assays, Antitumor; Humans; Imines; Microbial Sensitivity Tests; Molecular Structure; National Cancer Institute (U.S.); United States | 2008 |
In vitro antifungal susceptibilities of five species of sporothrix.
Topics: Animals; Antifungal Agents; Drug Resistance, Fungal; Humans; Microbial Sensitivity Tests; Species Specificity; Sporothrix; Sporotrichosis | 2008 |
Reliability of the WIDERYST susceptibility testing system for detection of in vitro antifungal resistance in yeasts.
Topics: Amphotericin B; Antifungal Agents; Azoles; Candida; Culture Media; Drug Resistance, Fungal; Fungi; Humans; Microbial Sensitivity Tests; Mycoses; Reproducibility of Results; Yeasts | 2008 |
Cell density and cell aging as factors modulating antifungal resistance of Candida albicans biofilms.
Topics: Antifungal Agents; Biofilms; Candida albicans; Cell Adhesion; Colony Count, Microbial; Culture Media; Drug Resistance, Fungal; Humans; Microbial Sensitivity Tests; Polystyrenes; Time Factors | 2008 |
Abc1p is a multidrug efflux transporter that tips the balance in favor of innate azole resistance in Candida krusei.
Topics: Amino Acid Sequence; Animals; Antifungal Agents; ATP-Binding Cassette Transporters; Azoles; Blotting, Northern; Blotting, Southern; Candida; Candidiasis; Cell Membrane; Chromosomes, Fungal; Drug Resistance, Fungal; Endoplasmic Reticulum; Humans; Phenotype; Plasmids; Reverse Transcriptase Polymerase Chain Reaction; Saccharomyces cerevisiae | 2009 |
In vitro activity of thimerosal against ocular pathogenic fungi.
Topics: Alternaria; Amphotericin B; Antifungal Agents; Aspergillus; Eye Infections, Fungal; Fungi; Fusarium; Humans; Microbial Sensitivity Tests; Natamycin; Thimerosal | 2010 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
Analysis of physico-chemical properties of substrates of ABC and MFS multidrug transporters of pathogenic Candida albicans.
Topics: Candida albicans; Membrane Transport Proteins; Saccharomyces cerevisiae; Structure-Activity Relationship; Substrate Specificity | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Synthesis and antifungal evaluation of head-to-head and head-to-tail bisamidine compounds.
Topics: Antifungal Agents; Candida; Cryptococcus neoformans; DNA-Binding Proteins; Furans; Humans | 2015 |
In vitro susceptibility and synergy studies of Aspergillus species to conventional and new agents.
Topics: Amphotericin B; Antifungal Agents; Aspergillus; Azoles; Drug Antagonism; Drug Resistance, Microbial; Drug Synergism; Flucytosine; Itraconazole; Ketoconazole; Miconazole; Microbial Sensitivity Tests | 1992 |
Drugs for treatment of fungal infections.
Topics: Amphotericin B; Antifungal Agents; Drug Interactions; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Mycoses; Opportunistic Infections | 1992 |
Tropical mycoses.
Topics: Adult; Aged; Antifungal Agents; Blastomycosis; Chromoblastomycosis; Drug Therapy, Combination; Female; Flucytosine; Histoplasmosis; Humans; Itraconazole; Ketoconazole; Male; Middle Aged; Mycetoma; Mycoses; South Africa; Sporotrichosis | 1992 |
In vitro antifungal spectrum of itraconazole and treatment of systemic mycoses with old and new antimycotic agents.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Cryptococcosis; Drug Therapy, Combination; Fluconazole; Flucytosine; Guinea Pigs; Immunocompromised Host; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Mycoses; Sporotrichosis | 1992 |
Comparative study of six antifungal treatments in an experimental model of murine cryptococcosis.
Topics: Amphotericin B; Animals; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Disease Models, Animal; Drug Administration Schedule; Drug Therapy, Combination; Fluconazole; Flucytosine; Itraconazole; Ketoconazole; Mice; Mice, Inbred BALB C; Triazoles | 1992 |
Ventriculitis and hydrocephalus caused by Candida albicans successfully treated by antimycotic therapy and cerebrospinal fluid shunting.
Topics: Adolescent; Amphotericin B; Antifungal Agents; Brain Abscess; Candidiasis; Cerebral Ventricles; Cerebrospinal Fluid; Combined Modality Therapy; Drug Therapy, Combination; Female; Flucytosine; Humans; Hydrocephalus; Itraconazole; Ketoconazole; Ventriculoperitoneal Shunt | 1992 |
In vitro susceptibility of 245 yeast isolates to amphotericin B, 5-fluorocytosine, ketoconazole, fluconazole and itraconazole.
Topics: Amphotericin B; Antifungal Agents; Candida; Fluconazole; Flucytosine; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Species Specificity | 1992 |
Itraconazole in cryptococcal meningitis in pregnancy: a case report.
Topics: Adult; Amphotericin B; Antifungal Agents; Female; Flucytosine; Humans; Infant, Newborn; Itraconazole; Ketoconazole; Meningitis, Cryptococcal; Pregnancy; Pregnancy Complications, Infectious | 1992 |
In vitro activity of cloconazole, sulconazole, butoconazole, isoconazole, fenticonazole, and five other antifungal agents against clinical isolates of Candida albicans and Candida spp.
Topics: Amphotericin B; Antifungal Agents; Candida; Candida albicans; Econazole; Flucytosine; Imidazoles; Ketoconazole; Miconazole; Microbial Sensitivity Tests | 1992 |
Evaluation of antifungal activity of antimycotics by automatic analyzing system.
Topics: Amphotericin B; Antifungal Agents; Antimycin A; Aspergillus niger; Ciclopirox; Flucytosine; Fungi; Griseofulvin; Image Processing, Computer-Assisted; Ketoconazole; Nystatin; Pyridones; Sodium Chloride | 1992 |
[Comparative study of two systems for the determination of the sensitivity of yeasts to antifungal agents].
Topics: Amphotericin B; Antifungal Agents; Candida; Candida albicans; Flucytosine; In Vitro Techniques; Ketoconazole; Miconazole; Microbial Sensitivity Tests | 1992 |
In vitro comparison of cilofungin alone and in combination with other antifungal agents against clinical isolates of Candida species.
Topics: Amphotericin B; Antifungal Agents; Candida; Candida albicans; Drug Therapy, Combination; Echinocandins; Flucytosine; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Peptides; Peptides, Cyclic | 1991 |
Treatment of chromoblastomycosis.
Topics: Antifungal Agents; Chromoblastomycosis; Drug Combinations; Flucytosine; Humans; Itraconazole; Ketoconazole | 1991 |
Candida zeylanoides: another opportunistic yeast.
Topics: Amphotericin B; Candida; Catheterization, Central Venous; DNA, Fungal; Drug Resistance, Microbial; Electrophoresis, Polyacrylamide Gel; Female; Fluconazole; Flucytosine; Humans; Ketoconazole; Microbial Sensitivity Tests; Middle Aged; Parenteral Nutrition, Total; Polymorphism, Restriction Fragment Length | 1991 |
[Meningitis caused by Candida albicans in a male patient infected by HIV and failure of treatment with amphotericin B].
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Candidiasis; Drug Therapy, Combination; Flucytosine; Humans; Immunocompromised Host; Ketoconazole; Male; Meningitis, Fungal | 1991 |
Treatment of cryptococcal meningitis with five anti-fungal drugs: the role of amphotericin B.
Topics: Amphotericin B; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Drug Therapy, Combination; Female; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Male; Meningitis; Miconazole; Middle Aged | 1990 |
In vitro susceptibility of 119 yeast isolates to fluconazole, 5-fluorocytosine, amphotericin B and ketoconazole.
Topics: Amphotericin B; Candida; Cryptococcus neoformans; Culture Media; Fluconazole; Flucytosine; Ketoconazole; Microbial Sensitivity Tests; Saccharomyces cerevisiae; Species Specificity; Yeasts | 1991 |
Clinical and experimental mycotic keratitis caused by Aspergillus terreus and the effect of subconjunctival oxiconazole treatment in the animal model.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus; Corneal Ulcer; Disease Models, Animal; Female; Flucytosine; Humans; Imidazoles; Ketoconazole; Male; Middle Aged; Morpholines; Rabbits | 1990 |
Preliminary results of treatment with itraconazole in patients with systemic fungal infections.
Topics: Acute Disease; Adult; Agranulocytosis; Antifungal Agents; Antineoplastic Agents; Drug Evaluation; Drug Therapy, Combination; Flucytosine; Humans; Itraconazole; Ketoconazole; Leukemia; Liver Function Tests; Middle Aged; Mycoses | 1990 |
False aneurysm infected by Aspergillus fumigatus: an unusual complication of aortofemoral bypass graft.
Topics: Amphotericin B; Aneurysm, Infected; Antifungal Agents; Aorta, Abdominal; Aspergillosis; Aspergillus fumigatus; Blood Vessel Prosthesis; Femoral Artery; Flucytosine; Humans; Itraconazole; Ketoconazole; Male; Middle Aged | 1990 |
Endogenous Candida endophthalmitis. Management without intravenous amphotericin B.
Topics: Adult; Aged; Amphotericin B; Candida; Candida albicans; Candidiasis; Endophthalmitis; Eye Infections, Fungal; Female; Flucytosine; Humans; Ketoconazole; Male; Middle Aged; Prognosis; Visual Acuity; Vitrectomy; Vitreous Body | 1990 |
Effects of incubation temperature, inoculum size, and medium on agreement of macro- and microdilution broth susceptibility test results for yeasts.
Topics: Amphotericin B; Candida; Culture Media; Flucytosine; Ketoconazole; Microbial Sensitivity Tests; Temperature; Triazoles; Yeasts | 1990 |
Chronic mucocutaneous candidiasis in childhood and complications of non-Candida infection: a report of the Pediatric Immunodeficiency Collaborative Study Group.
Topics: Adolescent; Amphotericin B; Autoimmune Diseases; Candidiasis; Candidiasis, Chronic Mucocutaneous; Child; Child, Preschool; Endocrine System Diseases; Family; Female; Flucytosine; Humans; Immunoglobulin A; Immunoglobulin G; Incidence; Infant; Infections; Ketoconazole; Lung Diseases; Male; Survival Rate | 1990 |
Drugs for treatment of fungal infections.
Topics: Amphotericin B; Antifungal Agents; Drug Interactions; Fluconazole; Flucytosine; Humans; Ketoconazole; Mycoses | 1990 |
Effect of methotrexate alone and in combination with antifungal drugs on the growth of Candida albicans.
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Drug Interactions; Flucytosine; Itraconazole; Ketoconazole; Methotrexate; Microbial Sensitivity Tests; Spores, Fungal; Time Factors | 1989 |
[Treatment of mycoses and new antifungal agents].
Topics: Allylamine; Amphotericin B; Antifungal Agents; Echinocandins; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Miconazole; Mycoses; Naphthalenes; Peptides; Peptides, Cyclic; Terbinafine | 1989 |
[Synergic effect of 5-fluorocytosine and imidazole derivatives against yeast strains resistant to 5-fluorocytosine].
Topics: Antifungal Agents; Candida; Drug Synergism; Fluconazole; Flucytosine; Humans; Imidazoles; Itraconazole; Ketoconazole; Miconazole; Yeasts | 1989 |
[Infections caused by Candida krusei in newborn infants].
Topics: Antifungal Agents; Candida; Candidiasis; Drug Therapy, Combination; Flucytosine; Humans; Infant, Newborn; Infant, Premature, Diseases; Ketoconazole; Miconazole | 1989 |
The use of 5-fluorocytosine and ketoconazole in the culture of the erythrocytic stages of Plasmodium falciparum and some tumor cell lines.
Topics: Animals; Cell Line; Drug Evaluation, Preclinical; Drug Screening Assays, Antitumor; Erythrocytes; Female; Flucytosine; Humans; Ketoconazole; Melanoma; Plasmodium falciparum; Tumor Cells, Cultured; Uterine Neoplasms | 1989 |
[Effect of synthetic antifungal drugs on the adherence of Candida albicans to the mouth mucosa epithelium in vitro].
Topics: Adhesiveness; Candida albicans; Clotrimazole; Epithelium; Female; Flucytosine; Humans; Imidazoles; In Vitro Techniques; Ketoconazole; Mouth Mucosa | 1989 |
Infections with Cryptococcus neoformans in the acquired immunodeficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; Amphotericin B; Cryptococcosis; Cryptococcus neoformans; Drug Therapy, Combination; Female; Flucytosine; Humans; Hyponatremia; Ketoconazole; Male; Meningitis; Middle Aged; Pancytopenia; Prognosis; Recurrence | 1989 |
Oral ketoconazole and flucytosine for neonatal systemic candidiasis.
Topics: Administration, Oral; Candidiasis; Drug Therapy, Combination; Flucytosine; Humans; Infant, Newborn; Infant, Premature, Diseases; Ketoconazole; Male | 1989 |
Combination therapy of experimental candidiasis, cryptococcosis, aspergillosis and wangiellosis in mice.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Cryptococcosis; Drug Therapy, Combination; Exophiala; Fluconazole; Flucytosine; Itraconazole; Ketoconazole; Mice; Mycoses; Triazoles | 1987 |
A comparison of the efficacy of itraconazole, amphotericin B and 5-fluorocytosine in the treatment of Aspergillus fumigatus endocarditis in the rabbit.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Endocarditis; Flucytosine; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Rabbits | 1987 |
[Experimental renal infection with Aspergillus fumigatus in mice: a chemotherapeutic model of an organic mycosis].
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Disease Models, Animal; Female; Flucytosine; Itraconazole; Ketoconazole; Kidney Diseases; Mice; Mice, Inbred Strains; Miconazole; Triazoles | 1985 |
Effects of imidazole- and triazole-derivative antifungal compounds on the growth and morphological development of Candida albicans hyphae.
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Clotrimazole; Flucytosine; Imidazoles; Itraconazole; Ketoconazole; Miconazole; Triazoles | 1985 |
Cryptococcus neoformans: comparisons of in vitro antifungal susceptibilities of serotypes AD and BC.
Topics: Amphotericin B; Antifungal Agents; Cryptococcus; Cryptococcus neoformans; Flucytosine; Itraconazole; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Nystatin; Serotyping; Triazoles | 1986 |
Renal aspergilloma--a case illustrating the problems of medical therapy.
Topics: Amphotericin B; Aspergillosis; Female; Flucytosine; Humans; Ketoconazole; Kidney Diseases; Middle Aged; Nephrectomy | 1987 |
[Incidence of mycotic infections in children with acute myeloblastic leukemia (AML)].
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Child; Clotrimazole; Drug Resistance, Microbial; Female; Flucytosine; Humans; Ketoconazole; Leukemia, Myeloid, Acute; Male; Miconazole; Nystatin | 1988 |
Influence of in vitro susceptibility testing conditions on the anti-candidal activity of LY121019.
Topics: Amphotericin B; Antifungal Agents; Candida; Culture Media; Echinocandins; Flucytosine; Humans; Hydrogen-Ion Concentration; Ketoconazole; Microbial Sensitivity Tests; Peptides; Peptides, Cyclic; Temperature; Time Factors | 1988 |
In vitro susceptibility of Cryptococcus neoformans isolates from patients with acquired immunodeficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Antifungal Agents; Cryptococcus; Cryptococcus neoformans; Flucytosine; Humans; Ketoconazole; Miconazole; Microbial Sensitivity Tests | 1988 |
[In vitro sensitivity of Aspergillus to terbinafine: comparative study on amphotericin B, 5-fluorocytosine and ketoconazole].
Topics: Amphotericin B; Antifungal Agents; Aspergillus; Flucytosine; Ketoconazole; Microbial Sensitivity Tests; Naphthalenes; Terbinafine | 1988 |
Combined effects of hyperbaric oxygen and antifungal agents on the growth of Candida albicans.
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Clotrimazole; Flucytosine; Hyperbaric Oxygenation; Ketoconazole; Miconazole; Nystatin; Time Factors | 1987 |
[Chromomycosis].
Topics: Amphotericin B; Chromoblastomycosis; Flucytosine; Humans; Ketoconazole; Male; Middle Aged; Mozambique | 1987 |
[The correlation between biotype and antifungal sensitivity of Candida albicans].
Topics: Candida albicans; Flucytosine; Humans; Ketoconazole; Microbial Sensitivity Tests; Mucous Membrane; Skin | 1987 |
Drugs for treatment of deep fungal infection.
Topics: Amphotericin B; Antifungal Agents; Drug Interactions; Flucytosine; Humans; Ketoconazole; Mycoses; Opportunistic Infections | 1988 |
Evaluation of single-drug and combination antifungal therapy in an experimental model of candidiasis in rabbits with prolonged neutropenia.
Topics: Agranulocytosis; Amphotericin B; Animals; Antifungal Agents; Candidiasis; Cytarabine; Drug Evaluation, Preclinical; Drug Therapy, Combination; Female; Flucytosine; Ketoconazole; Neutropenia; Rabbits; Rifampin | 1988 |
Hepatic candidiasis: an increasing problem in immunocompromised patients.
Topics: Adult; Amphotericin B; Biopsy; Candida; Candidiasis; Drug Therapy, Combination; Female; Flucytosine; Humans; Immunologic Deficiency Syndromes; Ketoconazole; Leukemia, Lymphoid; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Liver; Liver Diseases; Male | 1987 |
An outbreak of Candida parapsilosis endophthalmitis: analysis of strains by enzyme profile and antifungal susceptibility.
Topics: Amphotericin B; Candida; Candidiasis; Disease Outbreaks; Drug Contamination; Endophthalmitis; Flucytosine; Humans; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Postoperative Complications | 1987 |
The place of elective vitrectomy in the management of patients with Candida endophthalmitis.
Topics: Amphotericin B; Candidiasis; Endophthalmitis; Female; Flucytosine; Follow-Up Studies; Humans; Ketoconazole; Male; Visual Acuity; Vitrectomy | 1987 |
The influence of antifungal drugs on adherence of Candida albicans to buccal epithelial cells.
Topics: Adhesiveness; Amphotericin B; Antifungal Agents; Candida albicans; Candidiasis; Cheek; Dose-Response Relationship, Drug; Epithelium; Flucytosine; Humans; In Vitro Techniques; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Nystatin; Time Factors | 1986 |
Ketoconazole and flucytosine alone and in combination against Candida spp. in a neutropenic site in rabbits.
Topics: Animals; Candida; Candida albicans; Candidiasis; Drug Synergism; Drug Therapy, Combination; Flucytosine; Ketoconazole; Microbial Sensitivity Tests; Neutropenia; Rabbits | 1986 |
Effect of medium composition on results of macrobroth dilution antifungal susceptibility testing of yeasts.
Topics: Amphotericin B; Candida; Candida albicans; Cryptococcus neoformans; Culture Media; Flucytosine; Humans; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Yeasts | 1986 |
Cerebral phaeohyphomycosis.
Topics: Amphotericin B; Brain Abscess; Cladosporium; Drug Therapy, Combination; Female; Flucytosine; Humans; Ketoconazole; Middle Aged; Mycoses | 1987 |
High dose ketoconazole in the treatment of cerebral aspergilloma.
Topics: Adult; Amphotericin B; Aspergillosis; Brain Diseases; Drug Therapy, Combination; Female; Flucytosine; Hong Kong; Humans; Ketoconazole; Tomography, X-Ray Computed | 1987 |
Comparison of relative susceptibilities of Candida species to three antifungal agents as determined by unstandardized methods.
Topics: Agar; Amphotericin B; Antifungal Agents; Candida; Flucytosine; Ketoconazole; Microbial Sensitivity Tests | 1987 |
Management of cryptococcosis and toxic epidermal necrolysis in a dog.
Topics: Amphotericin B; Animals; Antifungal Agents; Cryptococcosis; Dog Diseases; Dogs; Drug Therapy, Combination; Female; Flucytosine; Ketoconazole; Stevens-Johnson Syndrome | 1987 |
Extensive subcutaneous hyphomycosis caused by Fusarium oxysporum.
Topics: Adolescent; Dermatomycoses; Female; Flucytosine; Fusarium; Humans; Ketoconazole | 1986 |
In vitro evaluation of various antifungal agents alone and in combination by using an automatic turbidimetric system combined with viable count determinations.
Topics: Amphotericin B; Antifungal Agents; Drug Interactions; Flucytosine; Ketoconazole; Microbial Sensitivity Tests; Nephelometry and Turbidimetry | 1986 |
[Progress in chemotherapeutic agents--antifungal agents].
Topics: Amphotericin B; Antifungal Agents; Flucytosine; Ketoconazole; Nystatin | 1986 |
Microtiter broth dilution method for yeast susceptibility testing with validation by clinical outcome.
Topics: Amphotericin B; Animals; Candida; Candidiasis; Culture Media; Flucytosine; Humans; Ketoconazole; Mice; Miconazole; Microbial Sensitivity Tests | 1986 |
Treatment of chromomycosis with a combination of ketoconazole and 5-fluorocytosine.
Topics: Adult; Aged; Chromoblastomycosis; Drug Therapy, Combination; Flucytosine; Humans; Ketoconazole; Male; Middle Aged | 1985 |
[Treatment Candida albicans endophthalmitis with ketoconazole].
Topics: Amphotericin B; Candidiasis; Endophthalmitis; Flucytosine; Humans; Ketoconazole | 1985 |
Cutaneous, ocular, and osteoarticular candidiasis in heroin addicts: new clinical and therapeutic aspects in 38 patients.
Topics: Adult; Aged; Amphotericin B; Bone Diseases; Candida albicans; Candidiasis; Candidiasis, Cutaneous; Eye Diseases; Female; Flucytosine; France; Heroin Dependence; Humans; Joint Diseases; Ketoconazole; Male; Middle Aged; Osteoarthritis; Scalp; Syndrome | 1985 |
Ketoconazole: clinical evaluation in severe fungal infections.
Topics: Adolescent; Adult; Aged; Drug Therapy, Combination; Female; Flucytosine; Humans; Ketoconazole; Male; Middle Aged; Mycoses | 1986 |
Drugs for treatment of systemic fungal infections.
Topics: Amphotericin B; Antifungal Agents; Drug Interactions; Drug Therapy, Combination; Flucytosine; Humans; Ketoconazole; Miconazole; Mycoses | 1986 |
Intraocular penetration of systemically administered antifungal agents.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Cataract Extraction; Drug Contamination; Eye; Flucytosine; Humans; Ketoconazole; Orbital Diseases; Postoperative Complications; Therapeutic Irrigation | 1985 |
Fungal peritonitis in patients on peritoneal dialysis: incidence, clinical features and prognosis.
Topics: Adult; Aged; Amphotericin B; Catheters, Indwelling; Drug Therapy, Combination; Female; Flucytosine; Humans; Ketoconazole; Male; Miconazole; Middle Aged; Mycoses; Peritoneal Dialysis; Peritonitis; Prognosis | 1985 |
Disseminated candidiasis with extensive folliculitis in abusers of brown Iranian heroin.
Topics: Adult; Amphotericin B; Candidiasis; Conjunctivitis; Female; Flucytosine; Folliculitis; Heroin; Humans; Iran; Ketoconazole; Male; Substance-Related Disorders | 1985 |
Simplified bioassay method for measurement of flucytosine or ketoconazole.
Topics: Amphotericin B; Biological Assay; Candida; Cytosine; Flucytosine; Humans; Ketoconazole | 1985 |
Cryptococcal meningitis.
Topics: Adolescent; Adult; Aged; Amphotericin B; Child; Cryptococcosis; Flucytosine; Follow-Up Studies; Garlic; Humans; Ketoconazole; Meningitis; Miconazole; Middle Aged; Plant Extracts; Plants, Medicinal | 1985 |
Systemic candidiasis in premature infants experience with drug treatment.
Topics: Amphotericin B; Candidiasis; Cytosine; Drug Therapy, Combination; Flucytosine; Humans; Infant, Newborn; Infant, Premature, Diseases; Ketoconazole; Miconazole | 1985 |
Isolated Candida arthritis: report of a case and definition of a distinct clinical syndrome.
Topics: Amphotericin B; Arthritis, Infectious; Candidiasis; Drug Therapy, Combination; Flucytosine; Humans; Injections, Intra-Articular; Ketoconazole; Knee Joint; Male; Middle Aged | 1985 |
Epidemic postsurgical Candida parapsilosis endophthalmitis. Clinical findings and management of 15 consecutive cases.
Topics: Aged; Amphotericin B; Candidiasis; Cataract Extraction; Eye Diseases; Female; Flucytosine; Humans; Ketoconazole; Male; Middle Aged; Ophthalmic Solutions; Therapeutic Irrigation | 1985 |
[Cryptococcus neoformans meningoencephalitis].
Topics: Aged; Amphotericin B; Antifungal Agents; Cryptococcosis; Drug Therapy, Combination; Flucytosine; Humans; Ketoconazole; Male; Meningoencephalitis; Miconazole; Prognosis | 1984 |
Broth dilution and disc diffusion methods in the susceptibility testing of pathogenic Candida albicans against four antimycotics.
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Chlorhexidine; Clotrimazole; Drug Resistance, Microbial; Flucytosine; Humans; Ketoconazole; Microbial Sensitivity Tests; Mouth; Stomatitis | 1984 |
Antimycotic therapy of experimental infections caused by dematiaceous fungi.
Topics: Amphotericin B; Animals; Antifungal Agents; Dose-Response Relationship, Drug; Drug Therapy, Combination; Flucytosine; Fluorouracil; Humans; Ketoconazole; Male; Mice; Mitosporic Fungi; Mycoses; Triazoles | 1984 |
Effective systemic antifungal agents.
Topics: Administration, Oral; Amphotericin B; Cytosine; Drug Evaluation; Drug Resistance, Microbial; Flucytosine; Half-Life; Humans; Infusions, Parenteral; Ketoconazole; Miconazole; Mycoses | 1984 |
Subcutaneous phaeohyphomycosis caused by Exophiala spinifera.
Topics: Flucytosine; Humans; Ketoconazole; Middle Aged; Mitosporic Fungi; Mycoses; Skin; Species Specificity | 1984 |
Relapse of Candida parapsilosis endocarditis after long-term suppression with flucytosin: retreatment with valve replacement and ketoconazole.
Topics: Adult; Amphotericin B; Candidiasis; Cytosine; Drug Therapy, Combination; Endocarditis; Female; Flucytosine; Heart Valve Prosthesis; Humans; Imidazoles; Ketoconazole; Mitral Valve; Piperazines; Recurrence | 1980 |
Ocular toxicity of topical antifungal agents.
Topics: Administration, Topical; Amphotericin B; Animals; Antifungal Agents; Cornea; Eye; Flucytosine; Imidazoles; Iritis; Ketoconazole; Miconazole; Piperazines; Rabbits | 1981 |
[Interactions between 5-fluorocytosine and polyene antibiotics, resp. imidazole derivatives (author's transl)].
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Cytosine; Drug Interactions; Econazole; Flucytosine; Imidazoles; Ketoconazole; Nystatin; Piperazines; Saccharomyces cerevisiae | 1981 |
Combined activity of ketoconazole and 5-fluorocytosine on potentially pathogenic yeasts.
Topics: Antifungal Agents; Candida; Cytosine; Drug Resistance; Drug Synergism; Flucytosine; Imidazoles; Ketoconazole; Piperazines; Yeasts | 1982 |
Drugs for treatments of systemic fungal infections.
Topics: Amphotericin B; Antifungal Agents; Flucytosine; Humans; Imidazoles; Ketoconazole; Miconazole; Mycoses; Piperazines | 1982 |
Therapy of superficial fungal infection.
Topics: Administration, Oral; Amphotericin B; Antifungal Agents; Candidiasis; Candidiasis, Oral; Dermatomycoses; Flucytosine; Griseofulvin; Humans; Imidazoles; Injections, Intravenous; Ketoconazole; Miconazole; Piperazines; Tinea; Tinea Versicolor | 1982 |
Treatment of experimental cryptococcal meningitis with amphotericin B, 5-fluorocytosine, and ketoconazole.
Topics: Amphotericin B; Animals; Cryptococcosis; Cryptococcus neoformans; Cytosine; Drug Synergism; Drug Therapy, Combination; Flucytosine; Imidazoles; Ketoconazole; Male; Meningitis; Piperazines; Rabbits | 1982 |
Susceptibility of dermatiaceous fungi to amphotericin B, miconazole, ketoconazole, flucytosine and rifampin alone and in combination.
Topics: Amphotericin B; Antifungal Agents; Cladosporium; Drug Synergism; Flucytosine; Imidazoles; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Mitosporic Fungi; Piperazines; Rifampin | 1982 |
Cutaneous phaeohyphomycosis of the sole caused by Exophiala jeanselmei and its susceptibility to amphotericin B, 5-FC and ketoconazole.
Topics: Amphotericin B; Antifungal Agents; Dermatomycoses; Drug Resistance, Microbial; Female; Flucytosine; Foot Dermatoses; Humans; Imidazoles; Ketoconazole; Middle Aged; Mitosporic Fungi; Piperazines | 1982 |
Interactions among amphotericin B, 5-fluorocytosine, ketoconazole, and miconazole against pathogenic fungi in vitro.
Topics: Amphotericin B; Antifungal Agents; Cytosine; Drug Synergism; Flucytosine; Fungi; Imidazoles; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Piperazines | 1982 |
Combination therapy of experimental candidiasis, cryptococcosis and aspergillosis in mice.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Cryptococcosis; Drug Synergism; Drug Therapy, Combination; Flucytosine; Imidazoles; Ketoconazole; Male; Mice; Piperazines | 1982 |
Antimicrobial treatment of systemic fungal infections.
Topics: Amphotericin B; Antifungal Agents; Flucytosine; Humans; Imidazoles; Ketoconazole; Miconazole; Mycoses; Piperazines | 1983 |
Determination of serum 5-fluorocytosine concentrations in the presence of ketoconazole.
Topics: Candida; Cytosine; Drug Interactions; Flucytosine; Ketoconazole; Microbial Sensitivity Tests | 1983 |
Hematogenous Candida spondylitis. A case report.
Topics: Amphotericin B; Candidiasis; Clindamycin; Drug Therapy, Combination; Female; Flucytosine; Humans; Ketoconazole; Lumbar Vertebrae; Middle Aged; Osteomyelitis; Spondylitis | 1984 |
Efficacy of antifungal agents in the cornea. II. Influence of corticosteroids.
Topics: Adrenal Cortex Hormones; Amphotericin B; Animals; Antifungal Agents; Candida albicans; Candidiasis; Drug Resistance, Microbial; Drug Therapy, Combination; Flucytosine; Keratitis; Ketoconazole; Miconazole; Natamycin; Rabbits | 1984 |
Drugs for treatment of systemic fungal infections.
Topics: Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Flucytosine; Humans; Ketoconazole; Miconazole; Mycoses | 1984 |
[Correlation of in vitro and in vivo actions of azole antimycotics].
Topics: Animals; Antifungal Agents; Candidiasis; Flucytosine; In Vitro Techniques; Ketoconazole; Male; Mice; Mice, Inbred Strains; Triazoles | 1984 |
In vitro susceptibilities of sucrose-negative Candida tropicalis, Candida lusitaniae, and Candida norvegensis to amphotericin B, 5-fluorocytosine, miconazole, and ketoconazole.
Topics: Amphotericin B; Candida; Culture Media; Cytosine; Drug Synergism; Flucytosine; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Sucrose | 1984 |
Combination of oral flucytosine and ketoconazole as therapy for experimental cryptococcal meningitis.
Topics: Amphotericin B; Animals; Cryptococcosis; Cryptococcus neoformans; Cytosine; Drug Synergism; Drug Therapy, Combination; Female; Flucytosine; Ketoconazole; Male; Meningitis; Mice; Mice, Inbred BALB C | 1984 |
In vitro susceptibilities of human and wild-type isolates of Basidiobolus and Conidiobolus species.
Topics: Amphotericin B; Antifungal Agents; Culture Media; Flucytosine; Fungi; Humans; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Potassium Iodide | 1984 |
In vitro activities of amphotericin B in combination with four antifungal agents and rifampin against Aspergillus spp.
Topics: Amphotericin B; Antifungal Agents; Aspergillus; Flucytosine; Ketoconazole; Microbial Sensitivity Tests; Rifampin; Triazoles | 1984 |
Influence of the corneal epithelium on the efficacy of topical antifungal agents.
Topics: Administration, Topical; Amphotericin B; Animals; Antifungal Agents; Candidiasis; Cornea; Corneal Diseases; Econazole; Epithelium; Flucytosine; Ketoconazole; Miconazole; Natamycin; Rabbits | 1984 |
Antimycotic activity of BAY N 7133 in animal experiments.
Topics: Administration, Oral; Administration, Topical; Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Cryptococcosis; Female; Flucytosine; Guinea Pigs; Hair; Infusions, Parenteral; Ketoconazole; Male; Mice; Mycoses; Triazoles | 1984 |
Systemic infection by Rhodotorula spp. in the immunocompromised host.
Topics: Adult; Amphotericin B; Bone Marrow; Flucytosine; Humans; Ketoconazole; Leukemia, Myeloid, Acute; Liver Abscess; Male; Mitosporic Fungi; Mycoses; Rhodotorula | 1984 |
Defining conditions for microbroth antifungal susceptibility tests: influence of RPMI and RPMI-2% glucose on the selection of endpoint criteria.
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Culture Media; Flucytosine; Glucose; Ketoconazole; Microbial Sensitivity Tests; Nephelometry and Turbidimetry | 1995 |
Drugs for AIDS and associated infections.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Antiprotozoal Agents; Antiviral Agents; Atovaquone; Candidiasis, Oral; Clindamycin; Clotrimazole; Cryptosporidiosis; Cytomegalovirus Infections; Dapsone; Didanosine; Drug Combinations; Drug Therapy, Combination; Fluconazole; Flucytosine; Folic Acid Antagonists; Foscarnet; Glucuronates; Herpes Simplex; Herpes Zoster; Humans; Isoniazid; Itraconazole; Ketoconazole; Lamivudine; Mycobacterium avium-intracellulare Infection; Naphthoquinones; Nystatin; Pentamidine; Pneumocystis Infections; Pneumonia, Pneumocystis; Prednisone; Primaquine; Reverse Transcriptase Inhibitors; Stavudine; Syphilis; Toxoplasmosis; Trimetrexate; Tuberculosis; Zalcitabine; Zidovudine | 1995 |
A comparison of susceptibility to five antifungal agents of yeast cultures from burn patients.
Topics: Amphotericin B; Antifungal Agents; Burns; Candida; Drug Resistance, Microbial; Fluconazole; Flucytosine; Humans; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Trichosporon; Yeasts | 1995 |
The postantibiotic effect of antifungal agents against common pathogenic yeasts.
Topics: Amphotericin B; Candida; Cryptococcus neoformans; Flucytosine; Ketoconazole; Miconazole; Microbial Sensitivity Tests | 1994 |
Comparison of broth dilution and semisolid agar dilution for in vitro susceptibility testing of Cryptococcus neoformans.
Topics: Amphotericin B; Antifungal Agents; Blood; Cerebrospinal Fluid; Cryptococcus neoformans; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Skin | 1994 |
Fungemia and colonization with nystatin-resistant Candida rugosa in a burn unit.
Topics: Amphotericin B; Burn Units; Burns; Candida; Candidiasis; Case-Control Studies; Cross Infection; Fluconazole; Flucytosine; Humans; Ketoconazole; Microbial Sensitivity Tests; Nystatin; Retrospective Studies | 1994 |
Systemic antifungal drugs.
Topics: Amphotericin B; Antifungal Agents; Drug Interactions; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Mycoses | 1994 |
Treatment of cryptococcal meningitis with short-course amphotericin B and flucytosine, followed by itraconazole.
Topics: Adult; Amphotericin B; Antifungal Agents; Female; Flucytosine; Humans; Itraconazole; Ketoconazole; Male; Meningitis, Cryptococcal; Middle Aged | 1993 |
Pharmacokinetics of antifungal agents.
Topics: Amphotericin B; Antifungal Agents; Fluconazole; Flucytosine; Humans; Ketoconazole; Mycoses; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis | 1993 |
Comparative effects of antifungal agents on zidovudine glucuronidation by human liver microsomes.
Topics: Amphotericin B; Antifungal Agents; Antiviral Agents; Chromatography, High Pressure Liquid; Fluconazole; Flucytosine; Glucuronates; Humans; Itraconazole; Ketoconazole; Miconazole; Microsomes, Liver; Zidovudine | 1995 |
Systemic antifungal drugs.
Topics: Amphotericin B; Antifungal Agents; Drug Interactions; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Mycoses | 1996 |
Multisite reproducibility of the Etest MIC method for antifungal susceptibility testing of yeast isolates.
Topics: Amphotericin B; Antifungal Agents; Candida; Evaluation Studies as Topic; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Quality Control; Reproducibility of Results | 1996 |
[Clinical fluconazole and itraconazole resistance of oro-gastrointestinal candidiasis in a patient with AIDS].
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Candida albicans; Candidiasis; Candidiasis, Oral; Drug Resistance, Multiple; Drug Therapy, Combination; Fluconazole; Flucytosine; Gastrointestinal Diseases; Humans; Ketoconazole; Male; Microbial Sensitivity Tests | 1996 |
Trichoderma harzianum peritonitis in peritoneal dialysis.
Topics: Aged; Aged, 80 and over; Antifungal Agents; Bacterial Infections; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Fatal Outcome; Flucytosine; Humans; Ketoconazole; Male; Mycoses; Peritoneal Dialysis; Peritonitis; Trichoderma | 1996 |
Susceptibility of Candida albicans pretreated with ketoconazole and 5-fluorocytosine to fungicidal activity of leukocytes and serum.
Topics: Antifungal Agents; Blood Physiological Phenomena; Candida albicans; Flucytosine; Humans; Ketoconazole; Neutrophils | 1995 |
Influence of human serum on the postantifungal effect induced by therapeutic concentrations of ketoconazole and 5-fluorocytosine.
Topics: Antifungal Agents; Blood; Candida albicans; Culture Media; Flucytosine; Humans; Ketoconazole | 1995 |
Effect of pH and buffer system on the in-vitro activity of five antifungals against yeasts.
Topics: Amphotericin B; Antifungal Agents; Buffers; Candida; Culture Media; Fluconazole; Flucytosine; Fungi; Hydrogen-Ion Concentration; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Reproducibility of Results; Species Specificity; Spectrophotometry | 1997 |
Rapid high performance liquid chromatographic assay for antifungal agents in human sera.
Topics: Amphotericin B; Antifungal Agents; Chromatography, High Pressure Liquid; Econazole; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Miconazole; Spectrophotometry, Ultraviolet | 1996 |
Systemic antifungal drugs.
Topics: Amphotericin B; Anorexia; Antifungal Agents; Aspergillosis; Blastomycosis; Candidiasis; Coccidioidomycosis; Cryptococcosis; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Dose-Response Relationship, Drug; Drug Interactions; Fluconazole; Flucytosine; Gynecomastia; Histoplasmosis; Humans; Itraconazole; Ketoconazole; Kidney Diseases; Liposomes; Male; Mixed Function Oxygenases; Mucormycosis; Nausea; Paracoccidioidomycosis; Sporotrichosis; Teratogens | 1997 |
[In vitro susceptibility to antifungal agents of Candida strains isolated from patients with various diseases of the respiratory tract].
Topics: Adult; Aged; Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Candida; Candidiasis; Fluconazole; Flucytosine; Humans; Ketoconazole; Microbial Sensitivity Tests; Middle Aged; Nystatin; Respiratory Tract Infections; Species Specificity; Sputum | 1997 |
Comparison of a 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-[(phenylamino)carbonyl]-2H-t etrazolium hydroxide (XTT) colorimetric method with the standardized National Committee for Clinical Laboratory Standards method of testing clinical yeast isolates for
Topics: Amphotericin B; Antifungal Agents; Candida; Colorimetry; Cryptococcus; Evaluation Studies as Topic; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests | 1998 |
The effect of limited exposure to antifungal agents on the germ tube formation of oral Candida albicans.
Topics: Adhesiveness; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Candida albicans; Candidiasis, Oral; Culture Media; Dose-Response Relationship, Drug; Fluconazole; Flucytosine; HIV Seronegativity; Humans; Ketoconazole; Microscopy, Electron, Scanning; Mouth; Nystatin | 1998 |
Adhesion of oral C. albicans to human buccal epithelial cells following limited exposure to antifungal agents.
Topics: Antifungal Agents; Candida albicans; Cell Adhesion; Cheek; Epithelial Cells; Female; Fluconazole; Flucytosine; Humans; Ketoconazole; Male; Microscopy, Electron, Scanning; Mouth Mucosa; Nystatin | 1998 |
Study of the susceptibility of yeast isolates of clinical interest to five antifungal agents using the E test.
Topics: Amphotericin B; Antifungal Agents; Candida; Cryptococcus neoformans; Drug Resistance, Microbial; Fluconazole; Flucytosine; Humans; In Vitro Techniques; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Prototheca | 1998 |
[Study of the in vitro sensitivity of yeasts with the ATB-Fungus system].
Topics: Amphotericin B; Antifungal Agents; Candida; Cryptococcus; Econazole; Flucytosine; Ketoconazole; Miconazole; Nystatin; Saccharomyces cerevisiae; Yeasts | 1998 |
Adhesion of oral Candida albicans isolates to denture acrylic following limited exposure to antifungal agents.
Topics: Adhesiveness; Administration, Topical; Amphotericin B; Analysis of Variance; Antifungal Agents; Candida albicans; Candidiasis, Oral; Denture Bases; Drug Administration Schedule; Fluconazole; Flucytosine; Humans; Image Processing, Computer-Assisted; Ketoconazole; Mouth; Nystatin; Polymethyl Methacrylate; Stomatitis, Denture; Surface Properties; Time Factors | 1998 |
Antifungal susceptibility of Candida isolates at the American University of Beirut Medical Center.
Topics: Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candidiasis; Fluconazole; Flucytosine; Hospitals, University; Humans; Itraconazole; Ketoconazole; Lebanon; Microbial Sensitivity Tests | 1998 |
Multicenter comparison of the sensititre YeastOne Colorimetric Antifungal Panel with the National Committee for Clinical Laboratory standards M27-A reference method for testing clinical isolates of common and emerging Candida spp., Cryptococcus spp., and
Topics: Amphotericin B; Antifungal Agents; Candida; Colorimetry; Cryptococcus; Fluconazole; Flucytosine; Guidelines as Topic; Itraconazole; Ketoconazole; Laboratories; Microbial Sensitivity Tests; Quality Assurance, Health Care; Reference Standards; Yeasts | 1999 |
The postantifungal effect (PAFE) of antimycotics on oral C. albicans isolates and its impact on candidal adhesion.
Topics: Acrylic Resins; Amphotericin B; Analysis of Variance; Antifungal Agents; Candida albicans; Cell Adhesion; Denture Bases; Fluconazole; Flucytosine; Ketoconazole; Microbial Sensitivity Tests; Nystatin | 1998 |
Comparative evaluation of Fungitest-, Neo-Sensitabs- and M27T-NCCLS broth microdilution methods for antifungal drug susceptibility testing of Candida species and Cryptococcus neoformans.
Topics: Amphotericin B; Antifungal Agents; Candida; Cryptococcus neoformans; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Reagent Kits, Diagnostic | 1999 |
Evaluation of a capacitance method for direct antifungal susceptibility testing of yeasts in positive blood cultures.
Topics: Amphotericin B; Antifungal Agents; Blood; Candida; Candida albicans; Culture Media; Drug Resistance, Microbial; Fluconazole; Flucytosine; Humans; Ketoconazole; Microbial Sensitivity Tests; Reproducibility of Results | 2000 |
Cryptococcal osteomyelitis of the spine.
Topics: Administration, Oral; Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Bone Transplantation; Child; Combined Modality Therapy; Cryptococcosis; Decompression, Surgical; Diagnosis, Differential; Female; Flucytosine; Humans; Ketoconazole; Male; Spondylitis | 1999 |
Susceptibility testing of Candida species: comparison of NCCLS microdilution method with Fungitest.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Drug Resistance, Microbial; Fluconazole; Flucytosine; Itraconazole; Ketoconazole; Miconazole; Microbial Sensitivity Tests | 2000 |
Antimicrobial susceptibility testing of dematiaceous filamentous fungi: effect of medium composition at different temperatures and times of reading.
Topics: Amphotericin B; Antifungal Agents; Colony Count, Microbial; Culture Media; Flucytosine; Fungi; Hot Temperature; Humans; Ketoconazole; Multivariate Analysis; Mycoses; Reproducibility of Results; Statistics, Nonparametric; Time Factors | 1999 |
Influence of pH and concentration on the postantifungal effect and on the effects of sub-MIC concentrations of 4 antifungal agents on previously treated Candida spp.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Fluconazole; Flucytosine; Hydrogen-Ion Concentration; Ketoconazole; Microbial Sensitivity Tests; Time Factors | 2000 |
In-vitro activity of five antifungal agents against uncommon clinical isolates of Candida spp.
Topics: Amphotericin B; Antifungal Agents; Candida; Fluconazole; Flucytosine; Itraconazole; Ketoconazole; Microbial Sensitivity Tests | 1999 |
Post-antifungal effect of polyene, azole and DNA-analogue agents against oral Candida albicans and Candida tropicalis isolates in HIV disease.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candidiasis, Oral; Fluconazole; Flucytosine; HIV Infections; Humans; Ketoconazole; Microbial Sensitivity Tests; Nystatin; Oropharynx; Pharyngeal Diseases; Statistics as Topic; Time Factors; Virulence | 2001 |
[In vitro antifungal susceptibility of dematiaceous filamentous fungi using the E-test].
Topics: Agar; Amphotericin B; Antifungal Agents; Colony Count, Microbial; Culture Media; Diffusion; Drug Resistance, Fungal; Fluconazole; Flucytosine; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Mitosporic Fungi | 2001 |
In vitro susceptibilities of Malassezia species to a new triazole, albaconazole (UR-9825), and other antifungal compounds.
Topics: Antifungal Agents; Drug Resistance, Fungal; Fluconazole; Flucytosine; In Vitro Techniques; Itraconazole; Ketoconazole; Malassezia; Microbial Sensitivity Tests; Pyrimidines; Quinazolines; Triazoles; Voriconazole | 2003 |
Experimental evaluation of antifungal and antiseptic agents against Rhodotorula spp.
Topics: Amphotericin B; Anti-Infective Agents, Local; Antifungal Agents; Drug Resistance, Fungal; Econazole; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Nystatin; Rhodotorula | 2003 |
Prevalence of Candida dubliniensis among germ tube-positive yeasts recovered from the respiratory specimens in HIV-negative patients.
Topics: Adult; Aged; Amphotericin B; Candida; Drug Resistance, Fungal; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Male; Microbial Sensitivity Tests; Middle Aged; Mycological Typing Techniques; Respiratory System; Saudi Arabia; Serotyping | 2004 |
In vitro susceptibility of Candida species isolated from cancer patients to some antifungal agents.
Topics: Amphotericin B; Antifungal Agents; Candida; Disease Susceptibility; Fluconazole; Flucytosine; Humans; Ketoconazole; Microbial Sensitivity Tests; Mycoses; Neoplasms; Oropharynx | 2004 |
Genome-wide expression profiling of the response to azole, polyene, echinocandin, and pyrimidine antifungal agents in Candida albicans.
Topics: Amphotericin B; Antifungal Agents; Azoles; Candida albicans; Caspofungin; Echinocandins; Flucytosine; Fungal Proteins; Gene Expression Profiling; Gene Expression Regulation, Bacterial; Genome, Fungal; Humans; Ketoconazole; Lipopeptides; Microbial Sensitivity Tests; Oligonucleotide Array Sequence Analysis; Peptides, Cyclic; Polyenes; Pyrimidines | 2005 |
[Allergic fungal sinusitis and allergic broncho-pulmonary aspergillosis: a fortuitous association or a nosological rhino-bronchial entity?].
Topics: Adult; Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Aspergillus; Combined Modality Therapy; Endoscopy; Female; Flucytosine; Follow-Up Studies; Humans; Immunoglobulin E; Itraconazole; Ketoconazole; Male; Middle Aged; Mycoses; Prednisolone; Respiratory Hypersensitivity; Retrospective Studies; Sinusitis; Time Factors; Treatment Outcome | 2005 |
In vitro susceptibilities of Malaysian clinical isolates of Cryptococcus neoformans var. grubii and Cryptococcus gattii to five antifungal drugs.
Topics: Amphotericin B; Antifungal Agents; Cryptococcus; Cryptococcus neoformans; Drug Resistance, Fungal; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests | 2006 |
Antifungal susceptibilities of the species of the Pseudallescheria boydii complex.
Topics: Amphotericin B; Antifungal Agents; Candida; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Lipopeptides; Lipoproteins; Micafungin; Microbial Sensitivity Tests; Naphthalenes; Peptides, Cyclic; Pseudallescheria; Pyrimidines; Quality Control; Quinazolines; Scedosporium; Terbinafine; Thiazoles; Triazoles; Voriconazole | 2006 |
Direct antifungal susceptibility testing of positive Candida blood cultures by sensititre YeastOne.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Pyrimidines; Reagent Kits, Diagnostic; Sensitivity and Specificity; Time Factors; Triazoles; Voriconazole | 2009 |
The post-antifungal effect (PAFE) of amphotericin B, nystatin, ketoconazole and 5-fluorocytosine and its impact on the colonization traits of Candida glabrata.
Topics: Amphotericin B; Antifungal Agents; Biofilms; Biomass; Candida glabrata; Candidiasis; Cell Adhesion; Cell Wall; Epithelial Cells; Flucytosine; Humans; Hydrophobic and Hydrophilic Interactions; Ketoconazole; Nephelometry and Turbidimetry; Nystatin | 2010 |
Antifungal susceptibility and virulence attributes of bloodstream isolates of Candida from Hong Kong and Finland.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidemia; Caspofungin; Drug Resistance, Fungal; Echinocandins; Finland; Fluconazole; Flucytosine; Hemolysin Proteins; Hong Kong; Humans; Itraconazole; Ketoconazole; Lipopeptides; Microbial Sensitivity Tests; Peptide Hydrolases; Pyrimidines; Triazoles; Virulence Factors; Voriconazole | 2011 |
Hydroxyurea therapy in sickle cell anemia patients aids to maintain oral fungal colonization balance.
Topics: Adolescent; Adult; Anemia, Sickle Cell; Antifungal Agents; Antisickling Agents; Candida; Candida glabrata; Candida tropicalis; Candidiasis, Oral; Case-Control Studies; Colony Count, Microbial; Cross-Sectional Studies; DMF Index; Drug Resistance, Fungal; Female; Fluconazole; Flucytosine; Humans; Hydroxyurea; Ketoconazole; Male; Microbial Sensitivity Tests; Middle Aged; Mouth; Saliva; Secretory Rate; Young Adult | 2013 |
In vitro activities of a wide panel of antifungal drugs against various Scopulariopsis and Microascus species.
Topics: Amphotericin B; Antifungal Agents; Ascomycota; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Itraconazole; Ketoconazole; Lipopeptides; Microbial Sensitivity Tests; Scopulariopsis; Triazoles; Voriconazole | 2015 |
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |